| Uniprot ID: | |
| Secondary ID: | |
| Symbol: | LncR-p21 |
| Other Name: | |
| Class: | Epigenetics |
| Type: | anti-fibrotic |
| Molecular Function: |
| Category I | Category II | Category III |
|---|---|---|
| Intracellular | Epigenetics | lncRNA |
Reference Record 1
| PubMed ID | 28592847 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
| Process I | regulate cytokines and growth factors | ||
| Process II | cells proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TGF-β signaling | ||
Reference Record 2
| PubMed ID | 28391277 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSC activation | ||
| Process III | |||
| Mechanism | Targeting Wnt/β-Catenin pathway | ||
Reference Record 3
| PubMed ID | 27610008 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSC activation | ||
| Process III | |||
| Mechanism | Targeting LincRNA-p21-miR-181b-PTEN signaling | ||